Skip to main content

Table 2 Prevalence of antibiotics resistance among MRSA and MSSA strains from the two groups of lesions

From: Methicillin-resistant Staphylococcus aureus colonization of infectious and non-infectious skin and soft tissue lesions in patients in Tehran

MRSA MSSA
  Infectious Group
N = 16
Non-infectious Group
N = 43
χ2, P-Value Total
N = 59
Infectious Group
N = 14
Non-infectious Group
N = 32
χ2, P- Value Total
N = 46
L 3(18.7%) 8(32%) .990 11(18.6%) 2(14.2%) 4(12.5%) .869 6(13.3%)
Mu 1(6.2%) 12(27.9%) .074 13(22%) 3(21.4%) 6(18.7%) .833 9(19.5%)
C 0 2(4.6%) .278 2(3.3%) 0 0 0
AK 2(12.5%) 8(18.6%) .578 10(16.9%) 0 1(3.1%) .504 1(2.1%)
T 8(50%) 13(30.2%) .159 21(35.5%) 5(35.7%) 8(25%) .458 13(28.2%)
PG 16(100%) 39(90.6%) .206 55(93.2%) 14(100%) 29(90.6%) .236 43(93.4%)
CIP 2(12.5%) 3(6.9%) .498 5(8.7%) 0 1(3.1%) .504 1(2.1%)
GM 1(6.2%) 4(9.3%) .708 5(8.7%) 0 0 0
SXT 7(43.7%) 10(23.2%) .122 17(28.8%) 1(7.1%) 2(6.2%) .910 3(6.5%)
E 8(50%) 16(37.2%) .374 24(40.6%) 5(35.7%) 13(40.6%) .754 18(39.1%)
CD 11(68.7%) 28(65.5%) .793 37(62.7%) 2(14.2%) 9(28.1%) .311 11(23.9%)
RA 6(37.5%) 15(34.8%) .852 21(35.5%) 1(7.1%) 4(12.5%) .591 5(10.8%)
  1. L linezolid, Mu mupirocin, C chloramphenicol, AK amikacin, FOX cefoxitin, T tetracycline, PG penicillin, CIP ciprofloxacin, GM gentamicin, SXT trimethoprim/sulfamethoxazole, E erythromycin, CD clindamycin, RA rifampin